Compare companies
Divi's Laboratories Limited | Sun Pharmaceutical Industries Limited | Cipla Limited | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 5839.2 | 1758.95 | 1476.2 | |||
Price priv. | ||||||
Number of shares, million | 265.47 | 2399.33 | 808 | |||
Capitalization, billion | 970.26 | 2720 | 997.27 | |||
EBITDA, billion | 25.43 | 138.36 | 67.2 | |||
EV, billion | 907.35 | 3800.17 | 1184.57 | |||
Profit and loss report | ||||||
Net profit, billion | 16 | 95.76 | 41.22 | |||
Revenue, billion | 78.45 | 477.58 | 257.74 | |||
EPS | 60.27 | 39.91 | 51.01 | |||
Balance | ||||||
Assets, billion | 154.7 | 854.63 | 327.18 | |||
Debt, billion | 0.03 | 32.74 | 5.59 | |||
Balance cost, billion | 135.71 | 636.67 | 267.06 | |||
Cash, billion | 3.63 | 92.86 | 6.4 | |||
Coefficients | ||||||
Dividend yield, % | 1.22 | 0.7986 | 1.39 | |||
Dividend | 30 | 15.5 | 13 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 49.75 | 30.26 | 16.65 | |||
P/S | 11.61 | 8.08 | 4.6 | |||
P/BV | 6.71 | 5.75 | 4.42 | |||
P/E | 56.93 | 40.31 | 28.76 | |||
Ev/Ebitda | 35.68 | 27.47 | 17.63 | |||
Debt/Ebitda | 0.0012 | 0.2366 | 0.0833 | |||
Efficiency | ||||||
ROE | 12.15 | 16.01 | 16.45 | |||
ROA | 10.7 | 11.52 | 13.26 | |||
ROIC | 20.52 | 18.08 | 14.41 | |||
Ebitda margin | 32.42 | 28.97 | 26.07 | |||
Net margin | 20.4 | 20.05 | 15.99 | |||
Momentum | ||||||
1 week, price changes | +0.3461 % | +0.0743 % | -2.3 % | |||
1 month, price changes | +2.02 % | +8.55 % | +1.06 % | |||
3 months, price changes | -0.7559 % | -4.88 % | -1.04 % | |||
6 months, price changes | +7.04 % | -10.12 % | -12 % | |||
1 year, price changes | +69.57 % | +8.08 % | -1.5 % | |||
3 years, price changes | +28.72 % | +90.26 % | +44.65 % | |||
5 years, price changes | +172.73 % | +367.45 % | +250.07 % | |||
10 years, price changes |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription